PSA testing for prostate cancer improves survival--but can we do better?

Lancet Oncol. 2010 Aug;11(8):702-3. doi: 10.1016/S1470-2045(10)70152-2. Epub 2010 Jul 2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Early Diagnosis
  • Humans
  • Male
  • Mass Screening*
  • Middle Aged
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / prevention & control*
  • Survival Rate
  • Sweden / epidemiology

Substances

  • Prostate-Specific Antigen